Tender Summary: Single Use Biopsy Forceps

Objectives

The primary objective is to procure and supply clinically compliant, single-use biopsy forceps to support gastrointestinal diagnostic and therapeutic procedures at Dr Pixley Ka Isaka Seme Memorial Hospital. The procurement aims to secure reliable medical equipment through a transparent, regulated, and preferentially weighted evaluation process.

Scope

The scope covers the supply of 1,000 units of single-use biopsy forceps. Responsibilities include manufacturing, packaging, transportation, and delivery to the designated hospital facility at the supplier's cost. The contract operates under a 90-day price validity period and utilises an 80/20 preference point evaluation system, where 80 points are allocated to price competitiveness and 20 points to socio-economic goals favouring South African-owned enterprises. Late submissions, expired products, or second-hand items are strictly excluded.

Technical Requirements

• Dimensions & Design: Working length of 230 cm, working channel of 2.8 mm, and overall diameter of 2.4 mm.
• Quality Standards: Items must be brand new, unused, and manufactured to the most recent design standards. Products must remain valid for a minimum of six months upon delivery.
• Regulatory Compliance: Mandatory possession of a valid licence issued by the South African Health Products Regulatory Authority (SAHPRA) permitting the manufacture, wholesale, or distribution of medical devices.
• Packaging & Logistics: Goods must be securely packaged to withstand transit conditions and delivered to the prescribed hospital address. All delivery costs must be embedded in the quoted price.
• Sample Evaluation: Compliant bidders may be formally invited to submit physical samples for objective testing prior to final contract award.

Skills & Experience Requirements

• Proven Healthcare Delivery: Bidders must demonstrate prior supply chain capability by submitting either proof of at least one successful delivery to a public or private health facility (order and delivery note) OR a financial capability statement showing a balance of not less than 40% of the quotation value (dated within one month).
• Administrative Competence: Ability to accurately complete all mandatory government procurement forms (SBD 4, SBD 6.1, GCC, SCC) without altering official templates, alongside maintaining active CSD registration, tax clearance, CIPC documentation, and B-BBEE verification.
• Financial & Contract Management: Capacity to sustain firm pricing throughout the validity period, manage performance security obligations, and adhere to strict delivery schedules without triggering penalty clauses.
• Regulatory & Quality Assurance Knowledge: Understanding of medical device distribution regulations, warranty obligations (12-month coverage), and third-party liability indemnification for intellectual property rights.

Unusual or Complicated Terms Explained

• SAHPRA Licence: A statutory regulatory permit required to legally import, manufacture, or distribute medical devices in South Africa. It certifies that products meet national safety, efficacy, and quality benchmarks before clinical deployment.
• 80/20 Preference Point System: A standard South African public procurement evaluation model. Eighty percent of scoring is based on price competitiveness, while twenty percent is reserved for specific socio-economic goals (here, promoting Black-owned or historically disadvantaged enterprises). Points are calculated mathematically against the lowest acceptable tender.
• Cover-Quoting Prohibition: An anti-collusion enforcement rule. If multiple quotations linked to shared directors, shareholders, or beneficial owners are submitted for this tender, all associated bids will be immediately disqualified as fraudulent cover-bidding.
• Performance Security & Prime Interest Penalties: Successful bidders must provide a bank guarantee or certified cheque within 30 days of award. Daily financial penalties are automatically deducted from the contract price at the prevailing prime interest rate for every day of delayed delivery, with potential contract termination and public sector procurement bans for repeated defaults.